There couldn’t be more at stake for California’s Democratic health care agenda in the presidential race. State lawmakers are already penning big-ticket legislation they hope to pursue should Democrat Joe Biden win, from single-payer to a new wealth tax.
Hospital staff in states such as California and New York can help patients obtain ballots and vote. In other states, you need a relative to assist you.
Democratic congressional candidates in California and beyond are linking their Republican opponents to the COVID-19 crisis and the survival of the Affordable Care Act, betting that health care could be a decisive issue for voters, especially in toss-up districts.
Ride-sharing and delivery services such as Uber, Lyft, DoorDash and Instacart are bankrolling California’s Proposition 22, which would keep their drivers classified as independent contractors, not employees. But health benefits? That’s something of a stretch.
A California woman thought the discount on her coinsurance before an operation sounded too good to be true. Turns out, she was right.
The volume of virtual medical appointments has exploded during the pandemic as patients and doctors have sought to avoid infection through in-person visits.
Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
Californians are again being asked to weigh in on a dialysis ballot measure. This one purports to target patient safety, and dialysis industry giants are once again spending big to defeat it.
Glimmers of hope are beginning to appear in the fight against the coronavirus, such as a decreasing death rate. But there’s not-so-good news, too, including a push for “herd immunity,” which could result in millions more deaths. Meanwhile, the Trump administration doubles down on work requirements for Medicaid. Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
More than a decade of research tied to California’s stem cell agency hasn’t yielded many cures or much revenue. But backers of a ballot initiative that asks voters for billions more in funding say the work is vital for patients and the scientific community.
